CAT vs SCNI · P/E 48, rev $37.96B vs P/E 0.2, rev $1.3M
Caterpillar Inc (CAT) versus Scinai Immunotherapeutics Ltd (SCNI) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
Latest reported CAT revenue for 2026-06-30 was $37.96B. Net income was $6.14B. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
Not investment advice. Open the CAT and SCNI stock pages for the full models.
Not investment advice.